High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.

MLA

Martin, Nicolas, et al. “High-Dose Chemotherapy with Carmustine, Etoposide, Cytarabine and Melphalan Followed by Autologous Stem Cell Transplant Is an Effective Treatment for Elderly Patients with Poor-Prognosis Lymphoma.” Leukemia & Lymphoma, vol. 56, no. 8, 2015, pp. 2379–87. EBSCOhost, https://doi.org/10.3109/10428194.2014.1001987.

APA

Martin, N., Borchiellini, D., Coso, D., Gastaud, L., Boscagli, A., Saudes, L., Re, D., Gutnecht, J., Garnier, G., Petit, E., Barriere, J., Naman, H., Rossignol, B., Thyss, A., & Peyrade, F. (2015). High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma. Leukemia & Lymphoma, 56(8), 2379–2387. https://doi.org/10.3109/10428194.2014.1001987

Chicago

Martin, Nicolas, Delphine Borchiellini, Diane Coso, Lauris Gastaud, Annick Boscagli, Laurence Saudes, Daniel Re, et al. 2015. “High-Dose Chemotherapy with Carmustine, Etoposide, Cytarabine and Melphalan Followed by Autologous Stem Cell Transplant Is an Effective Treatment for Elderly Patients with Poor-Prognosis Lymphoma.” Leukemia & Lymphoma 56 (8): 2379–87. doi:10.3109/10428194.2014.1001987.